Recent News

• 07.31.2026 - IRADIMED CORPORATION Reports Second Quarter 2026 Financial Results
• 07.24.2026 - IRADIMED CORPORATION to Hold Second Quarter 2026 Financial Results Conference Call on July 31, 2026
• 05.20.2026 - IRADIMED CORPORATION to Present at the Goldman Sachs 47th Annual Global Healthcare Conference
• 05.01.2026 - IRADIMED CORPORATION Reports First Quarter 2026 Financial Results
• 04.27.2026 - IRADIMED CORPORATION to Hold First Quarter 2026 Financial Results Conference Call on May 1, 2026
• 04.10.2026 - IRADIMED CORPORATION to Participate at the 25th Annual Needham Virtual Healthcare Conference
• 03.16.2026 - IRADIMED CORPORATION to Participate at the 38th Annual Roth Conference
• 02.10.2026 - IRADIMED CORPORATION Reports Record Fourth Quarter and Full Year of 2025 Financial Results and Increases its Regular Quarterly Cash Dividend to $0.20 Per Share from $0.17 Per Share
• 02.04.2026 - IRADIMED CORPORATION to Hold Fourth Quarter and Full Year 2025 Financial Results Conference Call on February 10, 2026
• 12.08.2025 - IRADIMED Announces Special Cash Dividend of $0.50 Per Share

Recent Filings

• 07.31.2026 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 07.31.2026 - EX-99.1 EX-99.1
• 07.31.2026 - 8-K Current report
• 07.28.2026 - SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors
• 06.24.2026 - 8-K Current report
• 06.23.2026 - 4 Statement of changes in beneficial ownership of securities
• 06.04.2026 - 4 Statement of changes in beneficial ownership of securities
• 06.04.2026 - 144 Report of proposed sale of securities
• 06.02.2026 - 4 Statement of changes in beneficial ownership of securities
• 05.28.2026 - 4 Statement of changes in beneficial ownership of securities